Anika Therapeutics reported $177.76M in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Abbott ABT:US $ 22627M 810M
Acceleron Pharma XLRN:US $ 717.77M 19.84M
Adamas Pharmaceuticals ADMS:US 115.66M 42.45M
Agenus AGEN:US $ 92.85M 42.81M
Agios Pharmaceuticals AGIO:US $ 1702.56M 652.55M
Anika Therapeutics ANIK:US $ 177.76M 4.29M
Arrowhead Research ARWR:US $ 525.96M 60.8M
Chemocentryx CCXI:US $ 317.13M 73.51M
Clovis Oncology CLVS:US $ 296.35M 43.84M
Dicerna Pharmaceuticals DRNA:US $ 616.49M 21.99M
Enanta Pharmaceuticals ENTA:US $ 321.15M 107.06M
Flexion Therapeutics FLXN:US $ 184.12M 20.5M
Halozyme Therapeutics HALO:US $ 999.75M 58.03M
Heron Therapeutics HRTX:US $ 366.83M 94.54M
Immunogen IMGN:US $ 274.4M 45.18M
Insmed INSM:US $ 1.04B 537.19M
Intrexon XON:US $ 156.68M 12.57M
Karyopharm Therapeutics KPTI:US $ 273.5M 17.99M
Ligand Pharmaceuticals LGND:US $ 410.9M 26.53M
Macrogenics MGNX:US $ 367M 7.72M
Merit Medical Systems MMSI:US $ 449.78M 11.29M
Peregrine Pharmaceuticals PPHM:US $ 200.78M 7.02M
Rigel Pharmaceuticals RIGL:US $ 184.2M 12.56M
Sangamo Biosciences SGMO:US $ 554.06M 52.88M
Stryker SYK:US $ 9032M 53M
Surmodics SRDX:US $ 94.11M 1.07M
Veracyte VCYT:US $ 371.35M 9.25M
Xencor XNCR:US $ 480.97M 110.2M
Zimmer Biomet Holdings Inc ZBH:US $ 5.36B 356.7M